This work demonstrates that insulin has direct effects on inflammatory cells in the brain, and may play an important role in the mechanism of action of insulin-based therapies currently being considered for CNS disorders including Alzheimer’s disease and TBI [42, 43]. The gene discussed is INS; the disease is early-onset autosomal dominant Alzheimer disease.